Head And Neck Cancer Drugs Market to Reach US$ 1,851.2 Mn by 2022: Key Players Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech, Inc.)
by The market is driven by the increasing prevalence of head and neck cancer globally. However, there are several obstacles in this market, such as the …